Cryogenic OGS Limited has submitted its compliance statement to BSE Limited regarding the utilization of funds raised through its initial public offering, confirming no deviations from the approved allocation for the half-year ended March 31, 2026. The statement, filed under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, was reviewed and approved by the company's audit committee and board of directors on April 30, 2026.

IPO Fund Details and Allocation

The company raised ₹17.76 crores through its initial public offer completed on July 10, 2025. The funds were allocated across three specific objectives as outlined in the original prospectus.

Fund Utilization Breakdown

The detailed utilization of IPO proceeds shows systematic deployment across the three approved categories. The company has utilized funds progressively towards its stated objectives without any modifications to the original allocation.

Compliance and Oversight

The fund utilization statement confirms that no monitoring agency oversight is required for this fundraising. Both the audit committee and external auditors have provided no adverse comments on the fund deployment strategy. The company has maintained transparency by making the statement available on its official website at cryogenicogs.com.

Corporate Governance

The statement was signed by Managing Director Nilesh Patel (DIN: 01368574) and Company Secretary & Compliance Officer Rashmi Kamlesh Otavani, demonstrating proper corporate governance protocols. The document confirms that no shareholder approval was required for any changes in fund utilization as no deviations occurred from the original objects of the issue.

Cryogenic ogs Limited has secured a significant order from Emerson Measurement Systems And Solutions India Pvt. Ltd, marking another milestone in its business operations. The company announced receipt of a Letter of Intent (LOI) valued at ₹2,12,66,380.00, excluding GST, for the supply of metering skids.

Order Details and Specifications

The comprehensive order details reveal the scope and nature of this business development:

Regulatory Compliance and Disclosure

The company made this announcement in strict adherence to regulatory requirements under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was submitted to BSE Limited on 17-04-2026, ensuring transparency for stakeholders and market participants.

Key compliance aspects include:

• Full disclosure under Schedule III Part A of SEBI LODR Regulations
• Confirmation of no promoter group interest in the awarding entity
• Verification that the transaction does not constitute a related party transaction
• Adherence to SEBI Circular guidelines for order disclosures

Business Impact and Execution

This order represents a substantial business opportunity for Cryogenic OGS Limited, formerly known as Cryogenic Liquide Pvt. Ltd. The company specializes in fluid metering and filtering equipment as an Original Equipment Manufacturer (OEM), positioning it well to execute this metering skids supply contract.

The 14-16 week execution timeline provides a clear delivery framework, allowing the company to plan production and resource allocation effectively. The domestic nature of the order strengthens the company's position in the Indian market while working with Emerson, a recognized name in measurement systems and solutions.

Corporate Governance Standards

The announcement demonstrates Cryogenic OGS Limited's commitment to maintaining high corporate governance standards. Company Secretary and Compliance Officer Rashmi Kamlesh Otavani signed the disclosure, ensuring proper authorization and compliance with regulatory frameworks. The detailed disclosure format provides stakeholders with comprehensive information about the order's terms, conditions, and business implications.